Anfield Capital Management »

Zentalis Pharmaceuticals shares owned by Anfield Capital Management

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Anfield Capital Management from 13F filings

Historical chart of Anfield Capital Management investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Anfield Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Anfield Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $238k 65k 3.68
2024-06-30 $40k 9.8k 4.09

More positions owned by Anfield Capital Management

Spdr S&p 500 Etf Trust Tr Unit (SPY)
Comm Serv Select Sector Spdr Communication (XLC)
Invesco Qqq Trust Series 1 Unit Ser 1 (QQQ)
Technology Select Sect Spdr Technology (XLK)
Anfield Us Equity Sector Rot Anfield Us Equ (AESR)
Health Care Select Sector Sbi Healthcare (XLV)
Vaneck Semiconductor Etf Semiconductor Et (SMH)
Ishares Us Treasury Bond Etf Us Treas Bd Etf (GOVT)
Invesco Fundamental High Yie Fndmntl Hy Crp (PHB)
Financial Select Sector Spdr Sbi Int-finl (XLF)
Ishares Iboxx Investment Gra Iboxx Inv Cp Etf (LQD)
Ishares Mbs Etf Mbs Etf (MBB)
Ishares 7-10 Year Treasury B Barclays 7 10 Yr (IEF)
Industrial Select Sect Spdr Sbi Int-inds (XLI)
Wisdomtree Japan Hedged Eq Japn Hedge Eqt (DXJ)

View all positions for Anfield Capital Management

Top funds holding Zentalis Pharmaceuticals

Matrix Capital Management Company
Eventide Asset Management
Vanguard Group
BlackRock
BlackRock
Decheng Capital
State Street Corporation
Citadel Advisors
Morgan Stanley
PRIMECAP Management Company
MPM Oncology Impact Management
Geode Capital Management
D. E. Shaw & Co
Woodline Partners
Two Sigma Investments

View all funds holding Zentalis Pharmaceuticals